|
|
|
|
|
21.08.26 - 00:03
|
XETR: DIVIDEND/INTEREST INFORMATION - 24.08.2026 - US88579Y1010 (XETRA)
|
|
|
Das Instrument MMM US88579Y1010 3M CO. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 21.08.2026 und ex Dividende/Zinsen am 24.08.2026
The instrument MMM US88579Y1010 3M CO. DL-,01 EQUITY has its pre-dividend/interest day on 21.08.2026 and its ex-dividend/interest day on 24.08.2026...
|
|
|
|
|
14.08.26 - 20:39
|
3M Board Declares Quarterly Dividend (PR Newswire)
|
|
|
ST. PAUL, Minn., Aug. 14, 2026 /PRNewswire/ -- The 3M Company Board of Directors (NYSE: MMM) today declared a dividend on the company's common stock of $0.78 per share for the third quarter of 2026. The dividend is payable Sept. 11, 2026, to shareholders of record at the close of business......
|
|
|
|
|
|
|
|
|
|
|
|
|
29.07.26 - 18:51
|
Andrew Costandi, MD, MMM, Named Anesthesiologist-in-Chief at Children′s Hospital Los Angeles (Business Wire)
|
|
|
LOS ANGELES--(BUSINESS WIRE)--Children's Hospital Los Angeles (CHLA) has appointed Andrew Costandi, MD, MMM, as Anesthesiologist-in-Chief and Department Chair of Anesthesiology Critical Care Medicine (ACCM), effective Aug. 1. In this leadership role, Dr. Costandi will oversee multiple clinical divisions at CHLA, including the Divisions of Clinical Anesthesiology, Pain Medicine, Palliative Care, and Critical Care Medicine, which includes the Cardiothoracic Intensive Care Unit and Pediatric Intensive Care Unit. In addition to ensuring high-quality clinical care across these teams, he will be responsible for advancing research and education programming; guiding strategic growth and quality improvement; leading recruitment and faculty development; managing financial priorities; and strengthening interdisciplinary partnerships with other teams across the enterprise. Dr. Costandi also serves as Professor of Clinical Anesthesiology at the Keck School of Medicine of USC.
“Since joining CHLA in 2015, Dr. Costan...
|
|
|
|
|
|
|
|
|
|
|
23.07.26 - 16:12
|
3M Aktie: Der Umbau trägt zunehmend Früchte (Aktiencheck)
|
|
|
Wien (www.aktiencheck.de) - 3M-Aktienanalyse der Raiffeisen Bank International AG:
Andreas Schiller, Analyst der Raiffeisen Bank International AG (RBI), stuft in einer aktuellen Aktienanalyse die Aktie von 3M Company (ISIN: US88579Y1010, WKN: 851745, Ticker-Symbol: MMM, NYSE-Symbol: MMM) von KAUF auf HALTEN herab. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
